HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption.

Abstract
High-fat diet (HFD) consumption has been demonstrated to cause peripheral and neuronal insulin resistance, and brain mitochondrial dysfunction in rats. Although the dipeptidyl peptidase-4 inhibitor, vildagliptin, is known to improve peripheral insulin sensitivity, its effects on neuronal insulin resistance and brain mitochondrial dysfunction caused by a HFD are unknown. We tested the hypothesis that vildagliptin prevents neuronal insulin resistance, brain mitochondrial dysfunction, learning and memory deficit caused by HFD. Male rats were divided into two groups to receive either a HFD or normal diet (ND) for 12 weeks, after which rats in each group were fed with either vildagliptin (3 mg/kg/day) or vehicle for 21 days. The cognitive function was tested by the Morris Water Maze prior to brain removal for studying neuronal insulin receptor (IR) and brain mitochondrial function. In HFD rats, neuronal insulin resistance and brain mitochondrial dysfunction were demonstrated, with impaired learning and memory. Vildagliptin prevented neuronal insulin resistance by restoring insulin-induced long-term depression and neuronal IR phosphorylation, IRS-1 phosphorylation and Akt/PKB-ser phosphorylation. It also improved brain mitochondrial dysfunction and cognitive function. Vildagliptin effectively restored neuronal IR function, increased glucagon-like-peptide 1 levels and prevented brain mitochondrial dysfunction, thus attenuating the impaired cognitive function caused by HFD.
AuthorsNoppamas Pipatpiboon, Hiranya Pintana, Wasana Pratchayasakul, Nipon Chattipakorn, Siriporn C Chattipakorn
JournalThe European journal of neuroscience (Eur J Neurosci) Vol. 37 Issue 5 Pg. 839-49 (Mar 2013) ISSN: 1460-9568 [Electronic] France
PMID23240760 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2012 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.
Chemical References
  • Dipeptidyl-Peptidase IV Inhibitors
  • Insulin Receptor Substrate Proteins
  • Irs1 protein, rat
  • Nitriles
  • Pyrrolidines
  • Glucagon-Like Peptide 1
  • Receptor, Insulin
  • Proto-Oncogene Proteins c-akt
  • Vildagliptin
  • Adamantane
Topics
  • Adamantane (analogs & derivatives, pharmacology)
  • Animals
  • Brain (drug effects, metabolism, physiology)
  • Cognition (drug effects)
  • Diet, High-Fat (adverse effects)
  • Dipeptidyl-Peptidase IV Inhibitors (pharmacology)
  • Gene Expression
  • Glucagon-Like Peptide 1 (genetics, metabolism)
  • Insulin Receptor Substrate Proteins (metabolism)
  • Insulin Resistance
  • Long-Term Synaptic Depression (drug effects)
  • Male
  • Maze Learning (drug effects)
  • Membrane Potential, Mitochondrial (drug effects)
  • Memory (drug effects)
  • Mitochondria (drug effects, physiology)
  • Neurons (metabolism)
  • Nitriles (pharmacology)
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Pyrrolidines (pharmacology)
  • Rats
  • Rats, Wistar
  • Receptor, Insulin (metabolism)
  • Vildagliptin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: